Neuren Pharmaceuticals | NEU - Pre Tax Profit

Stock Price
13.05
Daily Change
-0.39 -2.90%
Monthly
-23.68%
Yearly
-1.36%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD9.86M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -23.77M 12.2M Jun/2025
Clinuvel Pharmaceuticals AUD 35.87M 21.07M Jun/2024
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Genetic Signatures AUD -2.45M 2.08M Jun/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
Medical Developments International AUD -149K 466K Jun/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Organon & Co USD 243M 14M Sep/2025
PYC Therapeutics AUD -12.57M 13.3M Jun/2025
Starpharma Holdings AUD -2.3M 1.94M Jun/2025
Tectonic Therapeutic USD -19.04M 25K Sep/2025
Telix Pharmaceuticals AUD 76.73M 66.04M Jun/2025
Viatris USD -7.9M 209.2M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025